Seglcellesygdom (børn)
Behandling af vaso-okklusive episoder og akut brystsyndrom
Smertebehandling
What is the best pharmacologic treatment for sickle cell disease pain crises? (åbner nyt vindue)
Kilde: Ann Emerg Med 2012;59(6):515-6.
Indekseret: PubMed 22221839
DOI: 10.1016/j.annemergmed.2011.11.026
https://www.ncbi.nlm.nih.gov/pubmed/22221839 (åbner nyt vindue)
Multi-modal intervention and prospective implementation of standardized sickle cell pain admission orders reduces 30-day readmission rate. (åbner nyt vindue)
Kilde: Pediatr Blood Cancer 2009;53(3):401-5.
Indekseret: PubMed 19422031
DOI: 10.1002/pbc.22048
https://www.ncbi.nlm.nih.gov/pubmed/19422031 (åbner nyt vindue)
Reduction of painful vaso-occlusive crisis of sickle cell anaemia by tinzaparin in a double-blind randomized trial. (åbner nyt vindue)
Kilde: Thromb Haemost 2007;98(2):392-6.
Indekseret: PubMed 17721622
https://www.ncbi.nlm.nih.gov/pubmed/17721622 (åbner nyt vindue)
Væsketerapi (væskebehandling)
Fluid replacement therapy for acute episodes of pain in people with sickle cell disease. (åbner nyt vindue)
Kilde: Cochrane Database Syst Rev 2012;(6):CD005406.
Indekseret: PubMed 22696351
DOI: 10.1002/14651858.CD005406.pub3
https://www.ncbi.nlm.nih.gov/pubmed/22696351 (åbner nyt vindue)
Iltsupplering
Guidelines for the management of the acute painful crisis in sickle cell disease. (åbner nyt vindue)
Kilde: Br J Haematol 2003;120(5):744-52.
Indekseret: PubMed 12614204
https://www.ncbi.nlm.nih.gov/pubmed/12614204 (åbner nyt vindue)
Antibiotika og respiratorisk terapi
The use of incentive spirometry in pediatric patients with sickle cell disease to reduce the incidence of acute chest syndrome. (åbner nyt vindue)
Kilde: J Pediatr Hematol Oncol 2011;33(6):415-20.
Indekseret: PubMed 21792036
DOI: 10.1097/MPH.0b013e31821ed4ce
https://www.ncbi.nlm.nih.gov/pubmed/21792036 (åbner nyt vindue)
Safety of purified poloxamer 188 in sickle cell disease: phase I study of a non-ionic surfactant in the management of acute chest syndrome. (åbner nyt vindue)
Kilde: Hemoglobin 2004;28(2):85-102.
Indekseret: PubMed 15182051
https://www.ncbi.nlm.nih.gov/pubmed/15182051 (åbner nyt vindue)
Beneficial effect of intravenous dexamethasone in children with mild to moderately severe acute chest syndrome complicating sickle cell disease. (åbner nyt vindue)
Kilde: Blood 1998;92(9):3082-9.
Indekseret: PubMed 9787142
https://www.ncbi.nlm.nih.gov/pubmed/9787142 (åbner nyt vindue)
A short course of prednisone in the management of acute chest syndrome of sickle cell disease. (åbner nyt vindue)
Kilde: J Pediatr Hematol Oncol 2010;32(3):e91-4.
Indekseret: PubMed 20216237
DOI: 10.1097/MPH.0b013e3181c29c52
https://www.ncbi.nlm.nih.gov/pubmed/20216237 (åbner nyt vindue)
A randomized, placebo-controlled trial of arginine therapy for the treatment of children with sickle cell disease hospitalized with vaso-occlusive pain episodes. (åbner nyt vindue)
Kilde: Haematologica 2013;98(9):1375-82.
Indekseret: PubMed 23645695
DOI: 10.3324/haematol.2013.086637
https://www.ncbi.nlm.nih.gov/pubmed/23645695 (åbner nyt vindue)
Preliminary assessment of inhaled nitric oxide for acute vaso-occlusive crisis in pediatric patients with sickle cell disease. (åbner nyt vindue)
Kilde: JAMA 2003;289(9):1136-42.
Indekseret: PubMed 12622584
https://www.ncbi.nlm.nih.gov/pubmed/12622584 (åbner nyt vindue)
Predictors of bacteremia in febrile children with sickle cell disease. (åbner nyt vindue)
Kilde: J Pediatr Hematol Oncol 2002;24(4):279-83.
Indekseret: PubMed 11972096
https://www.ncbi.nlm.nih.gov/pubmed/11972096 (åbner nyt vindue)